(Q37409863)

English

The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers

scientific article published on 09 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers (English)

1 reference

Europe PubMed Central

20 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Hervé Wallerand

1

1 reference

Europe PubMed Central

20 August 2017

Grégoire Robert

2

1 reference

Europe PubMed Central

20 August 2017

Gilles Pasticier

3

1 reference

Europe PubMed Central

20 August 2017

Alain Ravaud

4

1 reference

Europe PubMed Central

20 August 2017

Philippe Ballanger

5

1 reference

Europe PubMed Central

20 August 2017

Robert E Reiter

6

1 reference

Europe PubMed Central

20 August 2017

Jean-Marie Ferrière

7

1 reference

Europe PubMed Central

20 August 2017

publication date

9 March 2009

1 reference

Europe PubMed Central

20 August 2017

Urologic Oncology

1 reference

Europe PubMed Central

20 August 2017

28

1 reference

Europe PubMed Central

20 August 2017

473-479

1 reference

Europe PubMed Central

20 August 2017

5

1 reference

Europe PubMed Central

20 August 2017

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Tumor metastasis: a new twist on epithelial-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

The early steps of neural crest development

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Induction and regulation of epithelial-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Epithelial-mesenchymal transitions: twist in development and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Epithelial-mesenchymal transitions in development and pathologies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Development of TGF-beta signalling inhibitors for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Twist is a potential oncogene that inhibits apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Snail blocks the cell cycle and confers resistance to cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Exploring a new twist on tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Mutations of the TWIST gene in the Saethre-Chotzen syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

A twist code determines the onset of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Recent advances in angiogenesis, anti-angiogenesis and vascular targeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Molecular histology in the study of solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

New drug development in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Survivin splice variants regulate the balance between proliferation and cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Improving outcomes with radical cystectomy for high-grade invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Cystectomy for bladder cancer: a contemporary series

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Significance of TWIST expression and its association with E-cadherin in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Induction of epithelial-mesenchymal transition-related genes by benzo[a]pyrene in lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.018

7 January 2021

Identifiers

10.1016/J.UROLONC.2008.12.018

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37409863&oldid=1856179596"